KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-4.46
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-4.14
Historical baseline
PeriodValueYoY Change
2025-4.46+4.2%
2024-4.66-43.9%
2023-3.24+17.9%
2022-3.94+75.0%
2021-15.76-266.5%
2020-4.30+53.6%
2019-9.26-185.2%
201810.87+467.5%
2017-2.96+20.3%
2016-3.71-